Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 13, 2017 - Issue 10
Submit an article Journal homepage
3,888
Views
30
CrossRef citations to date
0
Altmetric
Research Paper

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

Desmond CurranGSK, Wavre, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7423-0111
ORCID Icon,
Desirée Van OorschotGSK, Wavre, Belgium
,
Lijoy VargheseGSK, SingaporeORCID Iconhttps://orcid.org/0000-0002-6036-424X
ORCID Icon,
Lidia OostvogelsGSK, Wavre, Belgium
,
Tomas MrkvanGSK, Wavre, Belgium
,
Romulo ColindresGSK, Wavre, Belgium
,
Alfred von KrempelhuberGSK, München, Germany
&
Anastassia AnastassopoulouGSK, München, Germany
 show all
Pages 2213-2221 | Received 08 Mar 2017, Accepted 19 Jun 2017, Published online: 21 Sep 2017

Related Research Data

The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy
Source: Informa UK Limited
Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster.
Source: Springer Science and Business Media LLC
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
Source: (:unav)
Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
Source: Informa UK Limited

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.